Because many cancer cells escape cell death by activating the anti-apoptotic pathway such as via the upregulation of Mcl-1, BH3 mimetics are used for cancer treatment to inhibit anti-apoptotic activity and promote cell death [15]. Here, MCL1 is linked to cancer.